{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:57:35Z","timestamp":1790863055724,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.08.075","type":"journal-article","created":{"date-parts":[[2008,10,2]],"date-time":"2008-10-02T09:00:06Z","timestamp":1222938006000},"page":"161-168","source":"Crossref","is-referenced-by-count":79,"title":["Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15\u201325 years"],"prefix":"10.1016","volume":"27","author":[{"given":"Lars","family":"\u00d8stergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Lebacq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Poolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Maechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Boutriau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2008.08.075_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/14760584.6.4.485","article-title":"Neisseria vaccines 2007","volume":"6","author":"Findlow","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2008.08.075_bib2","unstructured":"European Union Invasive Bacterial Infections Surveillance Network. Invasive Neisseria meningitidis in Europe; 2006. Available from www.euibis.org\/documents\/2006_meningo.pdf (accessed January 22, 2008)."},{"issue":"20","key":"10.1016\/j.vaccine.2008.08.075_bib3","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.281.20.1906","article-title":"Risk of meningococcal infection in college students","volume":"281","author":"Harrison","year":"1999","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2008.08.075_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jama.286.6.694","article-title":"Invasive meningococcal disease in adolescents and young adults","volume":"286","author":"Harrison","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.08.075_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yapd.2005.03.005","article-title":"Meningococcal disease at the start of the 21st century","volume":"52","author":"Brandtzaeg","year":"2005","journal-title":"Adv Paediatr"},{"issue":"4","key":"10.1016\/j.vaccine.2008.08.075_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson Lecture. Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.08.075_bib7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.micinf.2005.01.003","article-title":"The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37\/ST-11 as an epidemic clone and the presence of serogroup A isolate in Burkina Faso","volume":"7","author":"Njanpop-Lafourcade","year":"2005","journal-title":"Microbes Infect"},{"issue":"37","key":"10.1016\/j.vaccine.2008.08.075_bib8","first-page":"313","article-title":"Enhanced surveillance of epidemic meningococcal meningitis in Africa: a three-year experience","volume":"80","author":"World Health Organization, Geneva","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"10.1016\/j.vaccine.2008.08.075_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3201\/eid0906.020565","article-title":"Serogroup W-135 meningococcal disease during the Hajj, 2000","volume":"9","author":"Lingappa","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"13","key":"10.1016\/j.vaccine.2008.08.075_bib10","first-page":"119","article-title":"Meningococcal disease, African meningitis belt, epidemic season","volume":"81","author":"World Health Organization","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2008.08.075_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","author":"Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.075_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.2007.57-c","article-title":"A multivalent conjugate vaccine for prevention of meningococcal disease in infants","volume":"299","author":"Harrison","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.08.075_bib13","unstructured":"Canada Communable Disease Report. Available from http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/07vol33\/dr3310ea.html (accessed January 25, 2008) 2007; 33(10)."},{"key":"10.1016\/j.vaccine.2008.08.075_bib14","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0264-410X(01)00299-7","article-title":"Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story","volume":"20","author":"Miller","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.075_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.08.075_bib16","series-title":"Proceedings of the 45th Annual Meeting of Infectious Diseases Society of America","article-title":"Effectiveness of serogroup C meningococcal conjugate vaccine (C-MCV): a 5-year follow-up in Quebec, Canada","author":"De Wals","year":"2007"},{"key":"10.1016\/j.vaccine.2008.08.075_bib17","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.39563.545255.AE","article-title":"Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study","volume":"336","author":"Snape","year":"2008","journal-title":"BMJ"},{"issue":"9320","key":"10.1016\/j.vaccine.2008.08.075_bib18","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"7385","key":"10.1016\/j.vaccine.2008.08.075_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/bmj.326.7385.365","article-title":"Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis","volume":"326","author":"Ramsay","year":"2003","journal-title":"BMJ"},{"issue":"29","key":"10.1016\/j.vaccine.2008.08.075_bib20","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1016\/j.vaccine.2007.04.071","article-title":"Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis","volume":"25","author":"De Wals","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.08.075_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/adc.2006.111500","article-title":"Meningococcal A, C, Y and W-135 polysaccharide\u2013protein conjugate vaccines","volume":"92","author":"Pace","year":"2007","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.075_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2008.08.075_bib23","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2008.08.075_bib24","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.08.075_bib25","unstructured":"Centers for Disease Control and Prevention (CDC). Inadvertent misadministration of meningococcal conjugate vaccine\u2014United States, June\u2013August 2005. MMWR 2006; 55(37):1016\u201317."},{"key":"10.1016\/j.vaccine.2008.08.075_bib26","unstructured":"WHO Expert Committee on Biological Standardization. 31st Report. WHO Technical Report Series 1981; 658:174\u201383."},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.075_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00003495-199855030-00003","article-title":"Meningococcal vaccines. Current status and future possibilities","volume":"55","author":"Peltola","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2008.08.075_bib28","unstructured":"World Health Organization. Group A and C meningococcal vaccines. WHO position paper. WER 1999; 74:297\u2013304."},{"key":"10.1016\/j.vaccine.2008.08.075_bib29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.08.075_bib30","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0264-410X(00)00282-6","article-title":"Pneumococcal otitis media and pneumococcal vaccines, a historical perspective","volume":"19","author":"Austrian","year":"2001","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.08.075_bib31","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2008.08.075_bib32","series-title":"Proceedings of the 45th annual meeting of infectious diseases society of America","article-title":"Immunogenicity at 12 months post-vaccination with novartis vaccines\u2019 tetravalent glycoconjugate meningococcal ACWY vaccine in adolescents","author":"Jackson","year":"2007"},{"key":"10.1016\/j.vaccine.2008.08.075_bib33","series-title":"Pediatric Academic Sciences & Asian Society for Pediatric Research Joint Meeting","article-title":"A phase III study comparing the safety and immunogenicity of a novel quadrivalent meningococcal conjugate vaccine MenACWY-CRM with the licensed MCV4 Menactra\u00ae in adolescents","author":"Jackson","year":"2008"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2008.08.075_bib34","doi-asserted-by":"crossref","first-page":"A101","DOI":"10.1016\/j.vaccine.2007.04.050","article-title":"Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults","volume":"25","author":"Kshirsagar","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08011912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:46:53Z","timestamp":1588967213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08011912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08011912"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}